Despite the number of new biomarkers, there is a lack of standardization, since CRC is only diagnosed by colonoscopy, faecal occult blood testing, and the presence of CEA in plasma, although these techniques present some disadvantages. The gene discussed is CEACAM5; the disease is colorectal carcinoma.